SCHEMBL9565301

SCHEMBL9565301

C=CCCCCCC=CCC(O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
ABCC4 O15439 1/20 0.47
LMNA P02545 3/20 0.44
USP2 O75604 3/20 0.44
CYP3A4 P08684 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RECQL P46063 2/20 0.44
FFAR1 O14842 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
FAAH O00519 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HPGD P15428 1/20 0.36
GMNN O75496 1/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX15 P16050 1/20 0.35
APEX1 P27695 1/20 0.35
CYP2C19 P33261 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9577926 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4
SCHEMBL9577944 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4
SCHEMBL9577848 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4
SCHEMBL9577972 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4
SCHEMBL9565334 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4
SCHEMBL9577740 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4
SCHEMBL9577970 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4
SCHEMBL9577718 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4
SCHEMBL9577850 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4
SCHEMBL9565289 1.00 MAPT (0.47) MAPTABCC4LMNAUSP2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0568307-A1 Cosmetic composition containing alpha hydroxy carboxylic acids as preservatives UNILEVER PLC (GB) 1993-11-03 EP claimed
EP-0442708-A2 Cosmetic composition UNILEVER PLC (GB) 1991-08-21 EP claimed
US-12082582-B2 Synergistic preservative compositions, process for preparing the same and method of use thereof ISP INVESTMENTS LLC (US) 2024-09-10 US disclosed
CN-113301802-B Synergistic preservative compositions, methods of making and methods of use thereof ISP投资有限公司 2023-08-25 CN disclosed
CN-107613767-B Synergistic preservative composition ISP投资有限公司 2022-06-21 CN disclosed
EP-3886582-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP Investments LLC (US) 2021-10-06 EP disclosed
WO-2020113211-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2020-06-04 WO disclosed
US-20180092357-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS ISP INVESTMENTS LLC (US) 2018-04-05 US disclosed
EP-3288380-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS ISP Investments LLC (US) 2018-03-07 EP disclosed
CN-107613767-A Cooperate with anticorrosive composite ISP投资有限公司 2018-01-19 CN disclosed
WO-2016164555-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS ISP INVESTMENTS INC. (US) 2016-10-13 WO disclosed
EP-0568307-A1 Cosmetic composition containing alpha hydroxy carboxylic acids as preservatives UNILEVER PLC (GB) 1993-11-03 EP disclosed
US-5227503-A 2-Hydroxyalkenoic acids CHESEBROUGH POND'S USA CO., DIVISION OF CONOPCO, INC. (US) 1993-07-13 US disclosed
US-5108751-A COSMETIC COMPOSITION COMPRISING 2-HYDROXYALKENOIC ACIDS OR A MIXTURE THEREOF CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) 1992-04-28 US disclosed
EP-0442708-A2 Cosmetic composition UNILEVER PLC (GB) 1991-08-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12082582-B2 Synergistic preservative compositions, process for preparing the same and method of use thereof HPD, EBP, TET1 MAPT 1525/4885ABCC4 4732/4885LMNA 384/4885
US-20180092357-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS PIEZO1, CASP1, PRNP MAPT 2190/4885ABCC4 3330/4885LMNA 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.